ES2109208T1 - Nuevas aplicaciones de un dimero de lisozima. - Google Patents

Nuevas aplicaciones de un dimero de lisozima.

Info

Publication number
ES2109208T1
ES2109208T1 ES96900321T ES96900321T ES2109208T1 ES 2109208 T1 ES2109208 T1 ES 2109208T1 ES 96900321 T ES96900321 T ES 96900321T ES 96900321 T ES96900321 T ES 96900321T ES 2109208 T1 ES2109208 T1 ES 2109208T1
Authority
ES
Spain
Prior art keywords
new applications
diseases
stimulation
lysozyme dimer
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES96900321T
Other languages
English (en)
Inventor
Witold Kiczka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nika Health Products Ltd
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of ES2109208T1 publication Critical patent/ES2109208T1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fish Paste Products (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES FARMACEUTICAS QUE CONTIENE UN DIMERO DE LISOZIMAS, PREFERENTEMENTE DE ALTA PUREZA, A SABER, CON UN 10 % EN PESO APROXIMADAMENTE O MENOS DE SUBPRODUCTOS NO INTENCIONADOS Y A NUEVAS APLICACIONES DE LAS MISMAS. TALES APLICACIONES INCLUYEN LA ADMINISTRACION TOPICA, ORAL Y PARENTERAL DE DICHAS COMPOSICIONES PARA UNA INMUNOESTIMULACION NO ESPECIFICA COMO MEDIDA DE PREVENCION Y/O TRATAMIENTO TERAPEUTICO DE ENFERMEDADES DE SERES HUMANOS Y ANIMALES QUE COMPRENDEN EL CANCER, TRASTORNOS EN EL CRECIMIENTO DEL CABELLO, ENFERMEDADES DE LOS PECES Y ENFERMEDADES DE LAS ABEJAS. LA ESTIMULACION NO ESPECIFICA DEL SISTEMA INMUNE SE INDUCE CON UNA APLICACION UNICA O REPETIDA DE LA COMPOSICION CON EL DIMERO DE LISOZIMAS, PREFERENTEMENTE A CONCENTRACIONES DE 5 A 500 {MI}G/KG DE PESO DEL CUERPO.
ES96900321T 1995-01-13 1996-01-13 Nuevas aplicaciones de un dimero de lisozima. Pending ES2109208T1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95100446 1995-01-13
EP95110638 1995-07-07

Publications (1)

Publication Number Publication Date
ES2109208T1 true ES2109208T1 (es) 1998-01-16

Family

ID=26138401

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96900321T Pending ES2109208T1 (es) 1995-01-13 1996-01-13 Nuevas aplicaciones de un dimero de lisozima.

Country Status (37)

Country Link
EP (2) EP1086703A3 (es)
JP (1) JPH10511974A (es)
KR (1) KR100420377B1 (es)
CN (1) CN1090506C (es)
AP (2) AP628A (es)
AT (1) ATE218367T1 (es)
AU (1) AU709620B2 (es)
BA (1) BA96074A (es)
BG (1) BG62239B1 (es)
BR (1) BR9606973A (es)
CA (1) CA2210091A1 (es)
CZ (1) CZ293353B6 (es)
DE (2) DE69621589D1 (es)
DZ (1) DZ1964A1 (es)
EA (1) EA001462B1 (es)
EE (1) EE9700154A (es)
ES (1) ES2109208T1 (es)
FI (1) FI972943L (es)
GB (1) GB2311724B (es)
GE (1) GEP20012571B (es)
GR (1) GR970300047T1 (es)
HR (1) HRP960014A2 (es)
HU (1) HU223903B1 (es)
IL (1) IL116737A (es)
MA (1) MA23775A1 (es)
MD (1) MD1633C2 (es)
MY (1) MY132437A (es)
NO (1) NO973203D0 (es)
NZ (1) NZ298432A (es)
OA (1) OA10436A (es)
PL (1) PL185678B1 (es)
SK (1) SK94297A3 (es)
SV (1) SV1996000001A (es)
TN (1) TNSN96004A1 (es)
TR (1) TR199700633T1 (es)
UA (1) UA50728C2 (es)
WO (1) WO1996021463A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
ATE211389T1 (de) * 1998-04-27 2002-01-15 Nika Health Products Ltd Zusammensetzung zur verbesserung der fruchtbarkeit und ihre verwendung
AUPP489798A0 (en) * 1998-07-28 1998-08-20 Mediko Pty Ltd Hair growth/maintenance compositions and methods
EP2134354A4 (en) * 2007-03-02 2012-03-21 Saint Simeon Lda COMPOSITION AND METHOD FOR THE TREATMENT OF PAPILLOMA VIRUS AND HORSE SARCODES
CN103518978B (zh) * 2013-10-22 2016-01-13 上海艾魁英生物科技有限公司 新型溶菌酶制剂及其制备方法
CN105828829A (zh) * 2013-12-18 2016-08-03 帝斯曼知识产权资产管理有限公司 用于含角蛋白的组织的包含溶菌酶水解物的组合物
CN104585546B (zh) * 2015-01-20 2019-02-05 上海海洋大学 一种促生长抗应激罗非鱼饲料及其制备方法
CN105707509B (zh) * 2016-01-25 2018-12-28 浙江艾杰斯生物科技有限公司 一种用于防治草鱼烂腮病的饲料添加剂
WO2020099556A1 (en) 2018-11-14 2020-05-22 Universiteit Antwerpen Oxidized lysozyme
EP4003300A4 (en) * 2019-07-26 2023-06-28 Infinant Health, Inc Nutritive compositions with bioactive proteins
CN111657407A (zh) * 2020-05-14 2020-09-15 上海艾魁英生物科技有限公司 提高断奶仔猪非特异性免疫功能的饲料添加剂、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
DE3230999A1 (de) * 1982-08-20 1984-02-23 Philips Kommunikations Industrie AG, 8500 Nürnberg Verfahren zur zugriffssteuerung bei einem nachrichtensystem
EP0181634A3 (en) * 1984-11-14 1987-09-09 Takeda Chemical Industries, Ltd. Synthetic gene for human lysozyme
RU2061496C1 (ru) * 1985-08-02 1996-06-10 Институт общей патологии и экологии человека Средство, стимулирующее эритропоэз
JPH01501939A (ja) * 1987-01-28 1989-07-06 オーソ・フアーマシユーチカル・コーポレーシヨン 免疫抑制ペプチドおよび使用法
US5200182A (en) * 1988-05-26 1993-04-06 Nika Health Products, Ltd. Antiviral or antibacterial composition and method of use
AU645252B2 (en) * 1990-01-08 1994-01-13 Nika Health Products Ltd. Method of producing ribonuclease dimers
CA2073351C (en) * 1990-01-08 2001-10-16 Nika Health Products, Inc. Lysozyme dimers and method of preparing them
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
RU2082413C1 (ru) * 1993-06-30 1997-06-27 Нижегородский государственный медицинский институт Способ лечения язвенной болезни двенадцатиперстной кишки
RU2071339C1 (ru) * 1994-07-25 1997-01-10 Щербакова Элеонора Григорьевна Средство для лечения и профилактики дисбактериоза
RU2123345C1 (ru) * 1997-07-31 1998-12-20 Научно-исследовательский институт детского питания Российской Академии сельскохозяйственных наук Средство для лечения дисбактериоза

Also Published As

Publication number Publication date
MA23775A1 (fr) 1996-10-01
EE9700154A (et) 1997-12-15
DZ1964A1 (fr) 2002-10-15
CA2210091A1 (en) 1996-07-18
HUP9801689A2 (hu) 1998-10-28
HUP9801689A3 (en) 2000-07-28
UA50728C2 (uk) 2002-11-15
ATE218367T1 (de) 2002-06-15
EA199700101A1 (ru) 1997-12-30
CN1090506C (zh) 2002-09-11
NO973203L (no) 1997-07-10
EP1086703A2 (en) 2001-03-28
IL116737A (en) 2000-02-17
EP0804227A2 (en) 1997-11-05
WO1996021463A3 (en) 1996-09-19
EA001462B1 (ru) 2001-04-23
FI972943A7 (fi) 1997-07-11
MD1633B2 (en) 2001-03-31
AP871A (en) 2000-09-10
CZ220297A3 (cs) 1998-02-18
HU223903B1 (hu) 2005-03-29
GB9714354D0 (en) 1997-09-10
OA10436A (en) 2001-12-07
GB2311724B (en) 1999-07-21
NO973203D0 (no) 1997-07-10
MD1633C2 (ro) 2001-10-31
GB2311724A (en) 1997-10-08
MY132437A (en) 2007-10-31
BG62239B1 (bg) 1999-06-30
NZ298432A (en) 2001-03-30
GEP20012571B (en) 2001-11-26
JPH10511974A (ja) 1998-11-17
AP628A (en) 1998-02-27
PL321546A1 (en) 1997-12-08
SK94297A3 (en) 1998-01-14
BR9606973A (pt) 1999-01-26
EP0804227B1 (en) 2002-06-05
DE69621589D1 (de) 2002-07-11
FI972943A0 (fi) 1997-07-11
GR970300047T1 (en) 1997-12-31
CZ293353B6 (cs) 2004-04-14
HRP960014A2 (en) 1997-12-31
MD970244A (en) 1999-05-31
AP9600783A0 (en) 1996-04-30
CN1177303A (zh) 1998-03-25
PL185678B1 (pl) 2003-07-31
DE804227T1 (de) 1998-04-09
KR100420377B1 (ko) 2004-05-20
FI972943L (fi) 1997-07-11
TR199700633T1 (xx) 1998-01-21
SV1996000001A (es) 1997-02-17
KR19980701337A (ko) 1998-05-15
BA96074A (bs) 1999-08-02
AU4391696A (en) 1996-07-31
WO1996021463A2 (en) 1996-07-18
AU709620B2 (en) 1999-09-02
BG101709A (en) 1998-03-31
IL116737A0 (en) 1996-05-14
EP1086703A3 (en) 2001-05-02
HK1002060A1 (en) 1998-07-31
TNSN96004A1 (fr) 2005-03-15
AP9701024A0 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
MY117892A (en) Therapeutic compounds
GR3025502T3 (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
BG86132A (bg) Производни на пиридазинамин
RU94028670A (ru) Иммунопотенциирующие агенты, способы лечения иммунодефицитных млекопитающих, а также вирусных инфекций и рака у млекопитающих
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
MX9302160A (es) Composiciones farmaceuticas del interferon de leu cocito humano concordante.
MY104575A (en) Therapeutic nucleosides.
ATE129404T1 (de) Dosierungsform fuer die freisetzung eines witkstoffs in einem kurzen zeitraum.
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
TR200101633T2 (tr) Farmasötik bileşim
MX9805441A (es) Compuestos terapeuticos.
SV1996000001A (es) Nuevas aplicaciones de dimero de lisozima
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
ES2130246T3 (es) Nucleosidos terapeuticos de la serie 2',3'-didesoxi-3'-fluoro-purina.
BR0313048A (pt) Uso de alquilfosfocolinas em combinação com medicamentos antitumorais
GB9509888D0 (en) Terpenoidic derivatives useful as antitumour agents
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
MX9303985A (es) Nucleosidos terapeuticos.
IT8448710A1 (it) Riduzione degli effetti tossici causati da farmaci antrachinonici
YU896A (sh) Farmaceutski sastav sa sadržajem lizozomskog dimera
MX9705246A (es) Nuevas aplicaciones de dimero de lisozina.
MX9300244A (es) Derivados de difluorometilenandrostenona y proceso para su preparacion.
TUI et al. IF MEDICINE
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.